{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:14Z","timestamp":1787960174276,"version":"build-2784847793"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ahj.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T01:30:33Z","timestamp":1371259833000},"page":"230-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Management of atrial fibrillation in chronic kidney disease: Double trouble"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct01478282","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Camus","family":"Nimmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ahj.2013.05.010_bb0005","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ahj.2013.05.010_bb0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ki.2011.416","article-title":"The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients","volume":"81","author":"Wetmore","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.ahj.2013.05.010_bb0020","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2013.05.010_bb0025","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjcard.2008.06.018","article-title":"Relation of atrial fibrillation to glomerular filtration rate","volume":"102","author":"Iguchi","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0030","article-title":"Cardiovascular Disease in chronic kidney disease: untying the Gordian knot (in press)","author":"Hajhosseiny","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.ahj.2013.05.010_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5527\/wjn.v1.i5.134","article-title":"Chronic kidney disease in acute coronary syndromes","volume":"1","author":"Marenzi","year":"2012","journal-title":"World J Nephrol"},{"issue":"2","key":"10.1016\/j.ahj.2013.05.010_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mhj.2002.125512","article-title":"Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data","volume":"144","author":"Reddan","year":"2002","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.STR.21.4.538","article-title":"Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators","volume":"21","year":"1990","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11255-010-9857-x","article-title":"Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients","volume":"42","author":"Miller","year":"2010","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2007111207","article-title":"Dilemmas in the management of atrial fibrillation in chronic kidney disease","volume":"20","author":"Reinecke","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ahj.2013.05.010_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1742-1241.2012.02954.x","article-title":"Cardiovascular disease in chronic kidney disease: untying the Gordian knot","volume":"67","author":"Hajhosseiny","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/HCO.0b013e328353b988","article-title":"Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence?","volume":"27","author":"Jenkins","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5301\/jn.5000154","article-title":"Dyslipidemia, statins, and CKD patients' outcomes\u2014review of the evidence in the post\u2013sharp era","author":"Heymann","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0075","series-title":"Heart Rhythm","article-title":"Rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III trial","author":"Williams","year":"2012"},{"issue":"10","key":"10.1016\/j.ahj.2013.05.010_bb0080","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1540-8167.2011.02069.x","article-title":"Renal dysfunction and atrial fibrillation recurrence following cardioversion","volume":"22","author":"Schmidt","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0085","series-title":"KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","author":"Foundation","year":"2004"},{"issue":"Suppl. M","key":"10.1016\/j.ahj.2013.05.010_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurheartj\/8.suppl_M.15","article-title":"The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance","volume":"8","author":"Payton","year":"1987","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1540-8167.2008.01187.x","article-title":"State of the art: catheter ablation of atrial fibrillation","volume":"19","author":"Wright","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.ahj.2013.05.010_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hrthm.2010.10.047","article-title":"Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up","volume":"8","author":"Naruse","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2013.05.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/j.1540-8167.2012.02422.x","article-title":"Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis","author":"Sairaku","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0110","unstructured":"CABANA trial (clinicaltrials.gov). In."},{"issue":"8","key":"10.1016\/j.ahj.2013.05.010_bb0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.ahj.2013.05.010_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2013.05.010_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mhj.2000.111111","article-title":"Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis","volume":"140","author":"V\u00e1zquez","year":"2000","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2013.05.010_bb0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.2009.185","article-title":"Atrial fibrillation in incident dialysis patients","volume":"76","author":"V\u00e1zquez","year":"2009","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.ahj.2013.05.010_bb0140","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2215\/CJN.02400311","article-title":"Warfarin in atrial fibrillation patients with moderate chronic kidney disease","volume":"6","author":"Hart","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ahj.2013.05.010_bb0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ahj.2013.05.010_bb0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2013.05.010_bb0155","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0272-6386(95)90123-X","article-title":"Defective platelet aggregation in uremia is transiently worsened by hemodialysis","volume":"25","author":"Sreedhara","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ahj.2013.05.010_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0300-2977(96)00005-8","article-title":"The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients","volume":"48","author":"Janssen","year":"1996","journal-title":"Neth J Med"},{"key":"10.1016\/j.ahj.2013.05.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2013.05.010_bb0175","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2013.05.010_bb0180","first-page":"33","article-title":"Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin","volume":"2","author":"Lai","year":"2009","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"7","key":"10.1016\/j.ahj.2013.05.010_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2013.05.010_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.ackd.2006.10.007","article-title":"Mechanisms of vascular calcification","volume":"14","author":"El-Abbadi","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/j.ahj.2013.05.010_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/bbrc.2001.5996","article-title":"Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall","volume":"289","author":"Spronk","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0200","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2005.05.014","article-title":"Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography","volume":"96","author":"Koos","year":"2005","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0205","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","article-title":"Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases","volume":"54","author":"Brodsky","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.ahj.2013.05.010_bb0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ahj.2013.05.010_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.007","article-title":"Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease","volume":"21","author":"Eikelboom","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"10.1016\/j.ahj.2013.05.010_bb0225","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","article-title":"Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy","volume":"55","author":"Angiolillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2013.05.010_bb0230","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.110.974683","article-title":"Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated?","volume":"122","author":"Montalescot","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2013.05.010_bb0235","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ahj.2013.05.010_bb0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ahj.2013.05.010_bb0245","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.05.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.112.001233","article-title":"Genetic determinants of dabigatran plasma levels and their relation to bleeding","author":"Par\u00e9","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.05.010_bb0255","article-title":"The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran","author":"Alikhan","year":"2013","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ahj.2013.05.010_bb0260","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2013.05.010_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/snep.2001.18379","article-title":"Arrhythmia issues in patients with renal disease","volume":"21","author":"Kocheril","year":"2001","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1016\/j.ahj.2013.05.010_bb0270","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/clc.4960230408","article-title":"Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?","volume":"23","author":"Varriale","year":"2000","journal-title":"Clin Cardiol"},{"issue":"9247","key":"10.1016\/j.ahj.2013.05.010_bb0280","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"K\u00f8ber","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahj.2013.05.010_bb0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000119694","article-title":"Paranoid psychosis and myoclonus: flecainide toxicity in renal failure","volume":"111","author":"Ting","year":"2008","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.ahj.2013.05.010_bb0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.ajkd.2007.10.034","article-title":"Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients","volume":"51","author":"Genovesi","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.ahj.2013.05.010_bb0295","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2013.05.010_bb0300","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ahj.2013.05.010_bb0305","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ndt\/gfr341","article-title":"Coumarins and survival in incident dialysis patients","volume":"27","author":"Knoll","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.ahj.2013.05.010_bb0310","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2013.05.010_bb0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.ahj.2013.05.010_bb0320","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1345\/aph.1R081","article-title":"Safe use of hemodialysis for dabigatran removal before cardiac surgery","volume":"46","author":"Wanek","year":"2012","journal-title":"Ann Pharmacother"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:49:35Z","timestamp":1757569775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0002870313003517"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.05.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of atrial fibrillation in chronic kidney disease: Double trouble","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}